News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Deuruxolitinib improves scalp hair regrowth in patients with severe AA
23 Apr 2026
byElaine Soliven
Treatment with deuruxolitinib, an oral Janus kinase 1/2 inhibitor, resulted in significant hair regrowth on the scalp for 24 weeks among patients with severe alopecia areata (AA), according to the two phase III THRIVE-AA1 and -AA2 trials presented at AAD 2026.
23 Apr 2026







